Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

Etats-Unis|Canada
English|French

Sesen Bio Inc

(NASDAQ: SESN)
Ajouter à Portefeuille
-0,02 (-1,67%)
en date du déc 6, 2019

Profil
Symbole SESN
Marché NASDAQ
Informations de contact
245 FIRST STREET SUITE 1800
CAMBRIDGE, MA USA
P: 617-444-8550
Président Thomas R. Cannell
Bénéfices à vue d'oeuil
Bénéfices 09/30/19
-0.13
06/30/19
-0.67
03/31/19
-0.08
12/31/18
-0.10
Ratio prix/bénéfices N/A
Croissance du BPA 32,73
Most Recent Earnings ($) -0,13
Annual EPS ($) -0,97
Résumé business
Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. The company's product portfolio includes Vicinium(TM) which is in its clinical trial treats high-grade non-muscle invasive bladder cancer. Sesen Bio Inc. formerly known as Eleven Biotherapeutics is based in Massachusetts United States.
Industrie/Secteur SIC-2834 Pharmaceutical Preparations
Medical - Biomedical